News and Announcements

View Archived News Stories »

LATEST NEWS

Antipsychotic Combinations vs. Monotherapy in Schizophrenia: A Meta-Analysis of Randomized Controlled Trials

Antipsychotic Combinations vs. Monotherapy in Schizophrenia: A Meta-Analysis of Randomized Controlled Trials

Read More »

Guideline Recommendations for the Diagnosis and Treatment of Adult ADHD without Comorbidity

Guideline Recommendations for the Diagnosis and Treatment of Adult ADHD without Comorbidity

Read More »

Latest Updates From The Agency for Health Care Administration

Get the latest updates from the Agency for Health Care Administration on information regarding mental health drugs.

Read More »

New Developments in the Treatment of Depression 2008-2009

ZYPREXA

Zyprexa has been approved (12-4-09) for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder.

Read More »

SEROQUEL

The FDA has approved the use of SEROQUEL in children and adolescents.

Read More »

At the Crossroads of Medicine and Policy: Psychotherapeutic Medications for Children

Florida Medicaid Drug Therapy Management Program for Behavioral Health in collaboration with Access Health in Pensacola, FL presented to an audience of mental health clinicians a program entitled “At the Crossroads of Medicine and Policy: Psychotherapeutic Medications for Children.”

Read More »

Updated Florida Best Practice Medication Guidelines for Adults

In July of 2009, the Florida Drug Therapy Management Program for Behavioral Health convened a panel of national experts and Florida mental health clinicians to update the Florida Best Practice Medication Guidelines for Adults.

Read More »

News from the Agency for Health Care Administration To Medicaid Providers

Effective April 25th, 2008, Medicaid will require a prior authorization for atypical anti-psychotics for children under the age of six years.

Read More »

Christoph Correll et al. Antipsychotic Combinations vs. Monotherapy in Schizophrenia

DISCUS and AIMS Scales

Florida Pediatric Psychiatry Hotline

AHCA Areas 1, 2a + 2b, 3a and 3b: 1-877-506-2720 AHCA Areas 4, 5, 6, 7 and 8: 1-866-487-9507 AHCA Areas 9, 10, and 11: 1-877-486-3783

Read More »

Barry Sarvet et al. Improving Access to Mental Health Care for Children

New: REGARDING THE USE OF ZIPRASIDONE IN CHILDREN AND ADOLESCENTS

Recommended doses for ziprasidone for children 6-11 and 12-17

Read More »

Don't Give Up Take Action!

Mental Health Association of Broward County

Read More »

Provider Alert Psychotherapeutic Consent

Effective September 1st, 2011 Medicaid will require that a Psychotherapeutic Consent Form accompany any new prescription for a psychotherapeutic medication prescribed for children from birth through the 13th birthday.

Read More »

FDA Safety Information for Celexa and Saphris

Henderson Behavioral Health Awarded $1.6 million SAMHSA Primary Care and Behavioral Healthcare Integration Grant

Psychotherapeutic Medication Guidelines for Children and Adolescents Updated

Doctors Prescribe Drugs as Neuro-enahncements?

View Archived News Stories »

Top ▲